Literature DB >> 19804739

Molecular dynamics simulations of Ibuprofen binding to Abeta peptides.

E Prabhu Raman1, Takako Takeda, Dmitri K Klimov.   

Abstract

Using replica exchange molecular dynamics simulations and the implicit solvent model we probed binding of ibuprofen to Abeta(10-40) monomers and amyloid fibrils. We found that the concave (CV) fibril edge has significantly higher binding affinity for ibuprofen than the convex edge. Furthermore, binding of ibuprofen to Abeta monomers, as compared to fibrils, results in a smaller free energy gain. The difference in binding free energies is likely to be related to the presence of the groove on the CV fibril edge, in which ibuprofen tends to accumulate. The confinement effect of the groove promotes the formation of large low-energy ibuprofen clusters, which rarely occur on the surface of Abeta monomers. These observations led us to suggest that the ibuprofen binding mechanism for Abeta fibrils is different from that for monomers. In general, ibuprofen shows a preference to bind to those regions of Abeta monomers (amino terminal) and fibrils (the CV edge) that are also the primary aggregation interfaces. Based on our findings and on available experimental data, we propose a rationale for the ibuprofen antiaggregation effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19804739      PMCID: PMC2756381          DOI: 10.1016/j.bpj.2009.07.032

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  60 in total

Review 1.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Kinetic analysis of beta-amyloid fibril elongation.

Authors:  Michelle J Cannon; Angela D Williams; Ronald Wetzel; David G Myszka
Journal:  Anal Biochem       Date:  2004-05-01       Impact factor: 3.365

3.  Replica exchange molecular dynamics simulations of amyloid peptide aggregation.

Authors:  M Cecchini; F Rao; M Seeber; A Caflisch
Journal:  J Chem Phys       Date:  2004-12-01       Impact factor: 3.488

Review 4.  Probing the pressure-temperature stability of amyloid fibrils provides new insights into their molecular properties.

Authors:  Filip Meersman; Christopher M Dobson
Journal:  Biochim Biophys Acta       Date:  2005-11-16

5.  Probing energetics of Abeta fibril elongation by molecular dynamics simulations.

Authors:  Takako Takeda; Dmitri K Klimov
Journal:  Biophys J       Date:  2009-06-03       Impact factor: 4.033

6.  Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.

Authors:  Michael T Heneka; Magdalena Sastre; Lucia Dumitrescu-Ozimek; Anne Hanke; Ilse Dewachter; Cuno Kuiperi; Kerry O'Banion; Thomas Klockgether; Fred Van Leuven; Gary E Landreth
Journal:  Brain       Date:  2005-04-07       Impact factor: 13.501

7.  Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro.

Authors:  Mie Hirohata; Kenjiro Ono; Hironobu Naiki; Masahito Yamada
Journal:  Neuropharmacology       Date:  2005-08-25       Impact factor: 5.250

8.  The structure of the Alzheimer amyloid beta 10-35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent.

Authors:  Andrij Baumketner; Joan-Emma Shea
Journal:  J Mol Biol       Date:  2006-11-10       Impact factor: 5.469

9.  Multiple ligand binding sites on A beta(1-40) fibrils.

Authors:  Harry LeVine
Journal:  Amyloid       Date:  2005-03       Impact factor: 7.141

10.  Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.

Authors:  Ann C McKee; Isabel Carreras; Lokman Hossain; Hoon Ryu; William L Klein; Salvatore Oddo; Frank M LaFerla; Bruce G Jenkins; Neil W Kowall; Alpaslan Dedeoglu
Journal:  Brain Res       Date:  2008-02-16       Impact factor: 3.252

View more
  17 in total

1.  Nonsteroidal anti-inflammatory drug naproxen destabilizes Aβ amyloid fibrils: a molecular dynamics investigation.

Authors:  Takako Takeda; Rashmi Kumar; E Prabhu Raman; Dmitri K Klimov
Journal:  J Phys Chem B       Date:  2010-10-27       Impact factor: 2.991

2.  On the origin of the stronger binding of PIB over thioflavin T to protofibrils of the Alzheimer amyloid-β peptide: a molecular dynamics study.

Authors:  Chun Wu; Michael T Bowers; Joan-Emma Shea
Journal:  Biophys J       Date:  2011-03-02       Impact factor: 4.033

3.  Unique example of amyloid aggregates stabilized by main chain H-bond instead of the steric zipper: molecular dynamics study of the amyloidogenic segment of amylin wild-type and mutants.

Authors:  Workalemahu Mikre Berhanu; Artëm E Masunov
Journal:  J Mol Model       Date:  2011-05-28       Impact factor: 1.810

4.  Naproxen interferes with the assembly of Aβ oligomers implicated in Alzheimer's disease.

Authors:  Seongwon Kim; Wenling E Chang; Rashmi Kumar; Dmitri K Klimov
Journal:  Biophys J       Date:  2011-04-20       Impact factor: 4.033

5.  Resveratrol inhibits the formation of multiple-layered β-sheet oligomers of the human islet amyloid polypeptide segment 22-27.

Authors:  Ping Jiang; Weifeng Li; Joan-Emma Shea; Yuguang Mu
Journal:  Biophys J       Date:  2011-03-16       Impact factor: 4.033

6.  Molecular dynamics simulations of anti-aggregation effect of ibuprofen.

Authors:  Wenling E Chang; Takako Takeda; E Prabhu Raman; Dmitri K Klimov
Journal:  Biophys J       Date:  2010-06-02       Impact factor: 4.033

7.  Molecular interactions of Alzheimer's biomarker FDDNP with Aβ peptide.

Authors:  Christopher Lockhart; Dmitri K Klimov
Journal:  Biophys J       Date:  2012-12-05       Impact factor: 4.033

8.  Molecular modeling to investigate the binding of Congo red toward GNNQQNY protofibril and in silico virtual screening for the identification of new aggregation inhibitors.

Authors:  Jian-Hua Zhao; Hsuan-Liang Liu; Pavadai Elumalai; Wei-Hsi Chen; Lee-Chung Men; Kung-Tien Liu
Journal:  J Mol Model       Date:  2012-07-27       Impact factor: 1.810

Review 9.  The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease.

Authors:  Justin A Lemkul; David R Bevan
Journal:  ACS Chem Neurosci       Date:  2012-08-27       Impact factor: 4.418

10.  Binding of Congo red to amyloid protofibrils of the Alzheimer Aβ(9-40) peptide probed by molecular dynamics simulations.

Authors:  Chun Wu; Justin Scott; Joan-Emma Shea
Journal:  Biophys J       Date:  2012-08-08       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.